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The use of self-reported symptoms as a
proxy for acute organophosphate
poisoning after exposure to chlorpyrifos
50% plus cypermethrin 5% among Nepali
farmers: a randomized, double-blind,
placebo-controlled, crossover study
Dea Haagensen Kofod1,2*, Erik Jørs2,3,4, Anshu Varma1,3,4, Shankuk Bhatta5 and Jane Frølund Thomsen1,3
Abstract
Background: Previous studies stating a high prevalence of occupational acute pesticide poisoning in developing
countries have mainly relied on measurements of the rather non-specific self-reported acute pesticide poisoning
symptoms. Only a few studies have measured the biomarker plasma cholinesterase (PchE) activity, in addition to the
symptoms, when assessing occupational acute pesticide poisoning. This study evaluated self-reported symptoms as a
proxy for acute organophosphate poisoning among Nepali farmers by examining self-reported acute organophosphate
poisoning symptoms and PchE activity in response to occupational acute organophosphate exposure.
Methods: We performed a randomized, double-blind, placebo-controlled, crossover trial among 42 Nepali commercial
vegetable farmers. The farmers were randomly assigned (ratio 1:1) to a 2-h organophosphate (chlorpyrifos 50% plus
cypermethrin 5%: moderately hazardous) spray session or a 2-h placebo spray session, and after 7 days’ washout, the
farmers were assigned to the other spray session. Before and after each spray session farmers were interviewed about
acute organophosphate poisoning symptoms and PchE activity was measured. Analyses were conducted with a Two
Sample T-test and Mann Whitney U-test.
Results: We found no difference in the symptom sum or PchE activity from baseline to follow up among farmers
spraying with organophosphate (symptom sum difference −1, p = 0.737; PchE mean difference 0.02 U/mL, p = 0.220),
placebo (symptom sum difference 9, p = 0.394; PchE mean difference 0.02 U/mL, p = 0.133), or when comparing
organophosphate to placebo (symptom p = 0.378; PchE p = 0.775). However, a high percentage of the farmers reported
having one or more symptoms both at baseline and at follow up in the organophosphate spray session (baseline 47.6%,
follow up 45.2%) and placebo spray session (baseline 35.7%, follow up 50.0%), and 14.3% of the farmers reported three or
more symptoms after the organophosphate spray session as well as after the placebo spray session.
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Conclusion: We found a general presence of acute organophosphate symptoms among the farmers regardless of
organophosphate exposure or poisoning. Thus, self-reported acute organophosphate symptoms seem to be a poor proxy
for acute organophosphate poisoning as the occurrence of these symptoms is not necessarily associated with acute
organophosphate poisoning.
Trial registration: ClinicalTrials.gov, NCT02838303. Registered 19 July 2016. Retrospectively registered.
Keywords: Farmers, Organophosphate, Acute pesticide poisoning, Symptoms, Plasma cholinesterase, Nepal
Background
Exposure to pesticides is considered as one of the most
important occupational health risks among farmers in de-
veloping countries [1, 2]. An estimated 25 million farmers
suffer from acute pesticide poisoning annually in develop-
ing countries, making pesticide poisoning a major global
health problem [2–4]. Some of the most widely used pesti-
cides of farmers worldwide, like organophosphates, cause
acute pesticide poisoning by inhibiting cholinesterase en-
zymes. This results in excessive stimulation of nicotinic
and muscarinic receptors causing the symptoms of acute
pesticide poisoning like headache, dizziness, weakness,
vomiting, diarrhea, bradycardia, dyspnea, ataxia, paralysis
and worst case death [5, 6].
Previous studies stating a high prevalence of occupa-
tional acute pesticide poisoning among farmers in devel-
oping countries [7–13] have mainly relied on measuring
self-reported acute pesticide poisoning symptoms when
assessing the prevalence. However, acute pesticide poison-
ing symptoms are rather non-specific and can have mul-
tiple causes such as heat exhaustion, dehydration, or
various diseases, and there may be some degree of recall
and report bias when relying on self-reported symptoms
solely. Thus, measuring cholinesterase enzyme activities,
in addition to acute pesticide poisoning symptoms, is sug-
gested when assessing occupational acute pesticide poi-
soning. Plasma cholinesterase (PchE) activity is considered
a valid biomarker of acute pesticide exposure and poison-
ing [5, 6, 14], however, to date only a few studies have
measured PchE activity in relation to occupational pesti-
cide poisoning [15–19] and these studies have mainly
examined occupational chronic pesticide poisoning.
The purpose of this study was to evaluate self-reported
symptoms as a proxy for acute organophosphate poison-
ing by examining self-reported acute organophosphate
poisoning symptoms and PchE activity in response to
occupational acute organophosphate exposure among
farmers in Nepal.
Methods
Study design
We performed a randomized, double-blind, placebo-
controlled, crossover trial collecting baseline and follow
up measures of self-reported acute organophosphate
poisoning symptoms and PchE activity in Nepali
farmers randomized to either Group A (farmers spray
with organophosphate in their first spray session and
placebo in their crossover spray session) or Group B
(farmers spray with placebo in first their spray session
and organophosphate in their crossover spray session).
The data presented was gathered by the principal inves-
tigator and a local partner over a 2-month period from
September to November 2014.
Study area, population and recruitment
Very few studies examining occupational acute pesti-
cide poisoning have been carried out in Nepal, how-
ever, the increasing pesticide consumption and health
hazardous pesticide behavior among Nepali farmers,
suggest a risk of significant exposure and poisoning
[9, 20, 21]. This study was conducted in two pur-
posely selected villages, Sukranagar and Jagatpur, in
the Chitwan District of Nepal, where vegetable pro-
duction is intensive and pesticide use extensive [22].
The study participants consisted of commercial vege-
table farmers. Inclusion criteria were: male, minimum
age 18 years, hand pressured backpack sprayer usage,
and used to spray with moderately to extremely haz-
ardous pesticides according to the World Health Or-
ganization’s (WHO) Pesticide Hazard Classification
[23]. Exclusion criteria were: usual personal protective
equipment use (respirator/mask with particulate filter,
face shield, googles, gloves, boots, plastic poncho),
unwilling to stay pesticide-free 7 days prior to each of
the two spray sessions, or medical conditions interfer-
ing with PchE activity (liver disease, acute infection,
chronic malnutrition, heart attack, cancer, obstructive
jaundice, inflammation caused by various diseases, or
use of pyridostigmine drugs) [24, 25].
The farmers were contacted through the management
in their respective Vegetable Farmer Cooperative, who
invited the farmers to a meeting regarding the study.
The farmers were informed about the purpose of the
study, its advantages and disadvantages, and were asked
to volunteer for the study. All participating farmers
signed an informed consent prior to participation. The
study was approved by Nepal Health Research Council’s
Ethical Review Board, Reg. no. 162/2014.
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Intervention
Each farmer participated in two spray sessions, which
each had an average duration of 2 h (minimum 1 h and
45 min; maximum 2 h and 15 min). Each spray session
was preceded by minimum 7 days’ washout in which the
farmers had to stay pesticide-free. In the organophos-
phate spray session the farmers sprayed with chlorpyri-
fos (organophosphate) 50% plus cypermethrin
(pyrethroid) 5% EC, WHO Class II: Moderately hazard-
ous, in the farmers’ usual dilution ratio. In the placebo
spray session the farmers sprayed with the biopesticide
Multineem, WHO Class U: Unlikely to present acute
hazard in normal use. The dilution ratio for Multineem
was 2 mL per L water. Multineem was purposely
selected, as it is similar to the organophosphate pesticide
in appearance and odor.
Data collection
A structured questionnaire interview and blood tests
were conducted in each farmer’s home just before (base-
line) and about 30 min after (follow up) each spray ses-
sion by the local partner. Observations were made based
on a checklist during each farmer’s spray session by the
principal investigator and the local partner. The struc-
tured questionnaire interview and observation checklist
were developed based on studies applying similar
methods [13, 21, 26, 27]. Under the supervision of the
principal investigator, the structured questionnaire inter-
view was conducted face-to-face in Nepali by the local
partner, and back translated into English later on the
same day.
Self-reported acute organophosphate poisoning symp-
toms were assessed with the baseline question “Have
you suffered from any of the following symptoms in the
last 7 days?” and follow up question “Have you suffered
from any of the following symptoms during or after
spraying today?”. The definition of symptoms was based
on WHO’s standardized list of clinical presentations of
acute organophosphate poisoning [2]. Some of these
clinical terms were considered difficult for the farmers
to understand, therefore, these terms were translated
into more understandable terms, the final list of self-
reported acute organophosphate poisoning symptoms
being: headache, dizziness, skin irritation, extreme tired-
ness, weakness, anxiety, excessive sweating, trembling
hands, vomiting, diarrhea, abdominal pain, blurred
vision, paralysis, salivation, tearing, lack of coordination,
respiratory difficulties, confusion.
PchE activity was measured with a blood test using a
Test-mate Che Cholinesterase System (Model 400) with
a PchE Plasma Cholinesterase Assay Kit (Model 470).
This system is considered to involve a reliable test
method for measuring PchE inhibition of farmers due to
organophosphate exposure [28, 29]. The blood test was
performed in accordance with the Instruction Manual
[30]. In short, after cleaning the farmer’s fingertip with
water, soap and an alcohol swap, the fingertip was punc-
tured with a sterile blood lancet, and a 10 microliter
capillary tube was filled with blood. The capillary tube
was inserted into an assay tube, and afterwards PchE
Plasma Cholinesterase Reagent was added. A photomet-
ric analyzer calculated the test results. Given the large
inter- and intraindividual variation of PchE, it is neces-
sary to establish individual baseline PchE activities,
adopted as a reference. The interindividual coefficient of
variation is about 15–25%, whereas the intraindividual
coefficient of variation is about 6–9% [31, 32]. PchE
activities after exposure should be expressed as percent-
age change with respect to the individual baseline [31].
A 50% PchE inhibition from baseline is suggested as the
level of acute overexposure and poisoning [5].
Descriptive variables partly included interviews about
the background characteristics age, height, weight,
marital status, educational level, farming experience,
pesticide experience, medical condition, medication, to-
bacco status, alcohol consumption, names of pesticides
the farmer usually uses, and partly observations of
temperature, clothing during spraying, work practices
during and after spraying, total area of spraying and if
the backpack leaked. In addition to the PchE activity,
we measured a hemoglobin (Hb) level with the Test-
mate Che Cholinesterase System to evaluate whether
the spray session resulted in dehydration of the
farmers, which would be reflected as an increase in Hb
level after spraying.
The informed consent, intervention, placebo and data
collection procedure were pretested on one commercial
vegetable farmer from Sukranagar. During pretesting of
the intervention and placebo both the farmer and the
local partner were unaware of the pesticide assignment
(placebo) chosen by the principal investigator, however,
both the farmer and the local partner believed that the
placebo was organophosphate.
Sample size calculation
The sample size calculation was based on data from a
previous study of 25 farmers in Chitwan whose acute
organophosphate poisoning symptoms significantly in-
creased after an organophosphate spray session (Neu-
pane D. Pesticide exposure and its health effects among
commercial vegetable farmers in Nepal. Unpublished
masters’ thesis. University of Southern Denmark; 2012).
The sample size was calculated using SAS 9.3 Proc
Power for paired means (alpha 0.05, power 0.90). A sam-
ple size of 34 pairs was required. Forty-two farmers were
enrolled taking into account possible dropouts and tech-
nical problems.
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Randomization and blinding
The participating farmers were assigned a study ID
number from 1 to 42. Forty-two opaque envelopes con-
taining a study ID card with a study ID number were
prepared by the principal investigator. A person not
involved in the project (Khilendra R. Chaudhary) ran-
domly allocated the envelopes to two buckets assigned
Group A or Group B (ratio 1:1). The person wrote the
assigned group on the study ID card, put the card back
into the envelope, wrote the study ID number on the
envelope, sealed the envelope and placed the envelopes
in numerical order. The envelopes were placed in a se-
cure location to which only the principal investigator
had access.
On the day of each farmer’s first spray session, the
principal investigator brought the numerically relevant
sealed envelope, and opened it prior to group assign-
ment. The principal investigator diluted the assigned
pesticide (organophosphate or placebo) into the farmer’s
backpack sprayer, while the farmer and the local partner
stayed at a location where they could not see the mixing
site. Afterwards, the backpack was handed to the farmer
closed and ready to use. This procedure was repeated
every time the farmer needed a backpack refill. Thus,
the principal investigator assigned all farmers to their
intervention, ensuring that the local partner and all
farmers remained unaware of the pesticide assignment.
Data analysis
Double data entry, cleaning and statistical analyses were
performed in SPSS version 22. P values lower than 0.05
were considered statistically significant. Mean (SD) was
applied for parametric tests and median (IQR) for non-
parametric tests. Body Mass Index was calculated as
weight (in kilograms) over height squared (in meters).
To compare the farmers’ characteristics between
Group A and Group B a two sample t-test was applied.
If the normality assumption was violated the Mann
Whitney U-test was applied. For categorical data the
Pearson Chi-Square test was applied, or when more than
20% of the cells had expected values less than five, Fish-
ers’ exact test (2×2 tables) and Likelihood Ratio (tables >
2×2) were applied.
To compare outcome measures between the organo-
phosphate spray session and the placebo spray session,
we used the model recommended by Altman and
colleagues for analyzing crossover trials consisting of
two sample t-tests or Mann Whitney U-tests [33]. First,
we applied the tests to assess whether there was any
period effect or treatment-period interaction, and given
the lack of such effects, we applied the same tests to
compare the two spray sessions.
To compare baseline levels within Group A and Group
B respectively, and to compare baseline levels and follow
up levels within the organophosphate and placebo spray
session respectively, we applied the paired sample t-test
when data were normally distributed and the Wilcoxon
signed rank test when data were not normally distributed.
Results
Figure 1 shows the trial profile. Of 44 eligible farmers,
two were excluded due to infectious leg ulcer and
unwillingness to stay pesticide-free 7 days prior to each
spray session. Forty-two farmers were randomized: 21 to
Group A and 21 to Group B. All randomized farmers
completed their assigned initial intervention and cross-
over intervention.
The farmers’ characteristics are described in Table 1,
which shows no statistically significant difference
between Group A and Group B. Ten farmers reported
having medical conditions: two reported mental prob-
lems (one medicated with fluoxetine 20 mg od. and
olanzapine 5 mg od., and one medicated with fluoxetine
40 mg od.); one had high blood pressure (medicated
with amlodipine 5 mg od.); seven had unmedicated, un-
specific symptoms such as gastritis and difficulties in
breathing. None of the conditions or medications are
known to interfere with PchE activity.
Table 2 describes ten of the most common pesticides
usually used by the farmers when spraying their crops. A
median of three different types of pesticides per farmer
was reported (IQR 2.0–4.0; minimum 1; maximum 6).
The most commonly used pesticide by the farmers, chlor-
pyrifos 50% plus cypermethrin 5% EC, was the pesticide of
choice for our organophosphate spray session.
Table 3 shows no considerable differences when com-
paring observations in the organophosphate spray ses-
sions with observations in the placebo spray sessions.
The median spraying time was 1.92 h (IQR 1.83–2.00 h)
with organophosphate and 2.00 h (IQR 2.00–2.00 h)
with placebo. In the organophosphate spray session the
farmers applied a median of 103 mL (IQR 80–136 mL)
chlorpyrifos 50% plus cypermethrin 5% EC per spray
session (median concentration: 1.8 mL/L water (IQR
1.6–1.9 mL/L)). There was no statistically significant
change in the Hb level from baseline to follow up among
farmers spraying with organophosphate (mean difference
−0.13 g/dL, −1.1%, p = 0.120) or with placebo (mean dif-
ference 0.06 g/dL, 0.5%, p = 0.526).
Table 4 shows that there was no statistically significant
change in PchE activity from baseline to follow up
among farmers spraying with organophosphate (mean
difference 0.02 U/mL, 1.25%, p = 0.220) or with placebo
(mean difference 0.02 U/mL, 1.25%, p = 0.133), or when
comparing organophosphate with placebo (p = 0.775).
The percentage changes in PchE activity from baseline
to follow up ranged between a maximum activation of
16.1% to a maximum inhibition of 10.9% after spraying
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with organophosphate, comparable to the changes after
spraying with placebo, which ranged between a max-
imum activation of 17.7% to a maximum inhibition of
9.1% (data not shown, see Additional file 1).
As for PchE, no statistically significant difference was
observed in the symptom sum from baseline to follow
up among farmers spraying organophosphate (sum
difference −1, p = 0.737), placebo (sum difference 9, p =
0.394), or when comparing organophosphate with pla-
cebo (p = 0.378). However, a high percentage of the
farmers reported having one or more symptoms consist-
ent with acute organophosphate poisoning both at
baseline and at follow up in the organophosphate spray
session (baseline 47.6%, follow up 45.2%) as well as in
the placebo spray session (baseline 35.7%, follow up
50.0%). After spraying with organophosphate, 23.8%
farmers increased their symptom sum, compared to
35.7% farmers after spraying with placebo (data not
shown, see Additional file 1).
For both outcome measures, there was no statistically
significant period effect (p = 0.946 for PchE, p = 0.171 for
symptoms) or treatment-period interaction (p = 0.108 for
PchE, p = 0.334 for symptoms) between the two spray ses-
sions. Furthermore, there was no statistically significant
difference in baseline levels between the organophosphate
and placebo spray session in Group A (p = 0.350 for PchE,
p = 0.903 for symptoms) or Group B (p = 0.351 for PchE,
p = 0.320 for symptoms).
Discussion
To our knowledge, this is the first placebo-controlled
study examining self-reported symptoms as a proxy for
acute organophosphate poisoning. The organophosphate
spray session did not increase self-reported symptoms or
Fig. 1 *1 excluded due to infectious leg ulcer, 1 excluded due to unwillingness to stay pesticide-free 7 days prior to each spray session
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decrease PchE activity, suggesting that a single 2-h spray
session with a moderately hazardous organophosphate
does not result in acute organophosphate poisoning
among farmers in our study.
Considering that 50% PchE inhibition is suggested as
the level of acute overexposure and poisoning [5], our
results on PchE inhibition did not indicate that any
farmer suffered from acute organophosphate poisoning.
Table 1 Characteristics of farmers
Variable Total (n = 42) Group A (n = 21) Group B (n = 21) P value*
Men, n (%) 42 (100) 21 (100) 21 (100)
Age (years) 0.134a
Mean (SD) 38.1 (9.4) 35.9 (8.6) 40.2 (10.0)
Education, n (%) 0.917+,b
No education 4 (9.5) 2 (9.5) 2 (9.5)
1st–4th grade 6 (14.3) 2 (9.5) 4 (19.0)
5th–8th grade 9 (21.4) 5 (23.8) 4 (19.0)
9th–12th grade 23 (54.8) 12 (57.1) 11 (52.4)
Median (IQR) 10 (4.8–10) 10 (6.0–10.0) 10 (3.0–10.0)
Involvement in farming (years), n (%) 0.208+,b
1–10 18 (42.9) 12 (57.1) 6 (28.6)
11–20 13 (31.0) 4 (19.0) 9 (42.9)
21–30 5 (11.9) 3 (14.3) 2 (9.5)
> 30 6 (14.3) 2 (9.5) 4 (19.0)
Median (IQR) 12.0 (8.0–22.3) 10.0 (6.0–21.5) 13.0 (10.0-24-0)
Pesticide use (years), n (%) 0.398+,b
1–10 24 (57.1) 15 (71.4) 9 (42.9)
11–20 13 (31.0) 3 (14.3) 10 (47.6)
21–30 5 (11.9) 3 (14.3) 2 (9.5)
Median (IQR) 10.0 (4.8–13.3) 8.0 (4.0–14.0) 11.0 (5.0–13.5)
Marital status, n (%) 0.148c
Currently married 36 (85.7) 18 (85.7) 18 (85.7)
Divorced/Separated 2 (4.8) 0 2 (9.5)
Never married 4 (9.5) 3 (14.3) 1 (4.8)
Body Mass Index (kg/m2) 0.505b
Median (IQR) 22.3 (19.8–24.9) 21.4 (18.3–25.9) 22.7 (21.4–23.4)
Alcohol drinking, n (%) 0.317d
Yes 13 (31.0) 5 (23.8) 8 (38.1)
No 29 (69.0) 16 (76.2) 13 (61.9)
Smoking, n (%) 1.000e
Yes 7 (16.7) 3 (14.3) 4 (19.0)
No 35 (83.3) 18 (85.7) 17 (81.0)
Chewing tobacco, n (%) 0.212d
Yes 18 (42.9) 11 (52.4) 7 (33.3)
No 24 (57.1) 10 (47.6) 14 (66.7)
* = For difference between Group A and Group B
+ = Tested as a continuous variable
a = Two sample t-test
b = Mann Whitney U-test
c = Likelihood Ratio
d = Fishers’ exact test
e = Pearson Chi-Square test
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To our knowledge, only one other study [34] has
assessed acute organophosphate poisoning using the
same method as we did by measuring follow up right
after the spray session. This study measured acetyl cho-
linesterase (AchE) before and after a 2-h spray session
with highly to extremely hazardous organophosphates
(WHO Class Ia and Ib) and in contrary to our results
found a significant inhibition of AchE, suggesting that a
2-h spray session with WHO Class Ia and Ib organo-
phosphates does produce acute health effects. The differ-
ence could be due to the difference in WHO Hazard
Class, and suggests that, as an initial approach to reduce
acute organophosphate poisoning, it may be of import-
ance to at least phase out farmers’ use of WHO Class I
organophosphates.
We found no considerable increase in self-reported
symptoms after the organophosphate or placebo spray
session, however, a high percentage of the farmers re-
ported having one or more symptoms both at baseline
and at follow up for the organophosphate spray session
(baseline 47.6%, follow up 45.2%) as well as the placebo
spray session (baseline 35.7%, follow up 50.0%). According
to WHO’s case definition matrix of acute organophos-
phate poisoning [2], a person is considered a probable
case of acute organophosphate poisoning if the person has
a known exposure of organophosphate, a temporal cause-
effect relationship, and reports three or more symptoms
of acute organophosphate poisoning. Applying this matrix,
we found that 14.3% of the farmers were classified as a
probable case of acute organophosphate poisoning at
follow up after the organophosphate spray session. How-
ever, 14.3% of the farmers also reported three or more
symptoms after the placebo spray session. Furthermore,
9.5% (for organophosphate) and 7.1% (for placebo) of
the farmers already reported having three or more
symptoms at baseline. No farmer’s change in PchE ac-
tivity indicated acute organophosphate poisoning. Thus,
using self-reported symptoms to assess acute organophos-
phate poisoning may lead to an overestimation, as there is
a general presence of symptoms consistent with acute or-
ganophosphate poisoning among the farmers regardless of
organophosphate exposure. In other words, the occur-
rence of these symptoms is not necessarily associated with
Table 2 Ten most common pesticides usually used by the farmers when spraying their crops (n = 42)
Active ingredient Chemical type Main use WHO Classa Reported use, n (%)
Chlorpyrifos 50% + cypermethrin 5% EC Organophosphate and pyrethroid Insecticide II 38 (90.5)
Emamectin Benzoate 5% SG Macrocyclic lactone Insecticide III 15 (35.7)
Carbendazim 12% +mancozeb 63% WP Benzimidazol and dithiocarbamate Fungicide U 12 (28.6)
Thiamethoxam 25% WG Neonicotinoid Insecticide III 8 (19.0)
Cypermethrin 10% EC Pyrethroid Insecticide II 7 (16.7)
Imidacloprid 17.8% SL Neonicotinoid Insecticide II 7 (16.7)
Dichlorvos 76% EC Organophosphate Insecticide Ib 6 (14.3)
Triazofos 35% + deltamethrin 1% EC Organophosphate and pyrethroid Insecticide II 5 (11.9)
Acetamiprid 20% SP Neonicotinoid Insecticide III 5 (11.9)
Cymoxanil 8% +mancozeb 64% WP Cyanoacetamide oxime and dithiocarbamate Fungicide III 5 (11.9)
aWorld Health Organization (WHO) Pesticide Hazard Classification of pesticide active ingredient: Ib Highly hazardous; II Moderately hazardous; III Slightly
hazardous; U Unlikely to present acute hazard in normal use
Table 3 Observed variables and change in Hb level in the
organophosphate spray session (OP) and in the placebo spray
session (PL)
Variable OP (n = 42) PL (n = 42)
Temperature (°C), mean (SD) 29.1 (3.3) 28.9 (3.5)
Area of land sprayed (Katha), median (IQR) 5.0 (4.0–6.6) 5.0 (3.9–6.0)
Leaking sprayer, n (%) 9 (21.4) 12 (28.6)
Clothing worn during spraying, n (%)
Long-sleeved shirt 18 (42.9) 17 (40.5)
Long pants 20 (47.6) 20 (47.6)
Hat 21 (50.0) 23 (54.8)
Cloth mask 8 (19.0) 12 (28.6)
Work practices during and after spraying, n (%)
Splash/spill on e.g. hands/feet 25 (59.5) 24 (57.1)
Spray against the wind 27 (64.3) 25 (59.5)
Walk in just sprayed crop 42 (100) 41 (97.6)
Keep nozzle close to the body 40 (95.2) 40 (95.2)
Nozzle direction in front of farmer 42 (100) 42 (100)
Adjust/repair equipment with bare hands 17 (40.5) 17 (40.5)
Eat/drink/smoke without prior hand wash 13 (31.0) 10 (23.8)
Suck/blow nozzle with mouth 5 (11.9) 2 (4.8)
Do not wash hands immediately
after spraying
4 (9.5) 5 (11.9)
Do not bath/change clothes soon
after spraying
14 (33.3) 14 (33.3)
Change in Hb level (g/dL) from baseline to
follow up, mean (SD)
−0.13 (0.54) 0.06 (0.65)
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acute organophosphate poisoning, as they are non-
specific, making them a poor proxy for acute organophos-
phate poisoning. This suggests that future studies should
not solely rely on self-reported symptoms when assessing
acute organophosphate poisoning but include biomonitor-
ing to achieve sound estimates. Such a mixed approach
might be helpful in identifying the most important areas
of intervention to reduce acute organophosphate poison-
ing among farmers in developing countries.
Even though our study did not find that the farmers suf-
fer from occupational acute organophosphate poisoning,
their work practices still raise potential acute and chronic
poisoning concerns. Our study, as well as other studies
from developing countries [7–9, 21, 26, 35], show that
farmers have unsafe work practices exposing them to
pesticides. About 58% of the farmers splashed/spilled pes-
ticides and 41% adjusted their pesticide spraying equip-
ment with bare hands. Thus, if the farmers spray with
WHO Class I pesticides, or spray for longer than the 2 h
that are considered to reflect farmers’ usual spraying time
[27, 34, 36], while applying unsafe work practices, a con-
siderable risk of acute organophosphate poisoning can be
expected. Furthermore, long-termed exposure to low
doses of hazardous pesticides are linked to adverse health
effects in immune, hematological, nervous, endocrine and
reproductive systems as well as DNA damage [2, 16].
Thus, interventions promoting safe work practices redu-
cing farmers’ hazardous pesticide exposure are needed to
reduce farmers’ risk of acute pesticide poisoning and
chronic sequelae of pesticide exposure.
Table 4 Results of the outcome measures for the organophosphate spray session (OP) and the placebo spray session (PL)
Variable OP (n = 42) PL (n = 42) P value*
Baseline Follow up Baseline Follow up
PchE activity (U/mL)
Mean (SD) 1.58 (0.41) 1.60 (0.40) 1.58 (0.42) 1.60 (0.41) 0.775a
Symptoms
Sum of all symptoms 42 41 31 40 0.378b
Number of symptoms per farmer, n (%)
0 22 (52.4) 23 (54.8) 27 (64.3) 21 (50.0)
1 11 (26.2) 10 (23.8) 6 (14.3) 10 (23.8)
2 5 (11.9) 3 (7.1) 6 (14.3) 5 (11.9)
≥ 3 4 (9.5) 6 (14.3) 3 (7.1) 6 (14.3)
Distribution, n (%)
Headache 6 (14.3) 10 (23.8) 4 (9.5) 10 (23.8)
Dizziness 1 (2.4) 1 (2.4) 2 (4.8) 6 (14.3)
Skin irritation 7 (16.7) 9 (21.4) 3 (7.1) 10 (23.8)
Extreme tiredness 4 (9.5) 5 (11.9) 6 (14.3) 5 (11.9)
Weakness 6 (14.3) 3 (7.1) 4 (9.5) 2 (4.8)
Anxiety 3 (7.1) 1 (2.4) 0 (0.0) 1 (2.4)
Excessive sweating 5 (11.9) 4 (9.5) 1 (2.4) 0 (0.0)
Trembling hands 1 (2.4) 1 (2.4) 1 (2.4) 1 (2.4)
Vomiting 0 (0.0) 0 (0.0) 1 (2.4) 0 (0.0)
Diarrhea 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Abdominal pain 1 (2.4) 2 (4.8) 1 (2.4) 1 (2.4)
Blurred vision 4 (9.5) 1 (2.4) 3 (7.1) 4 (9.5)
Paralysis 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Salivation 1 (2.4) 1 (2.4) 1 (2.4) 0 (0.0)
Tearing 0 (0.0) 0 (0.0) 2 (4.8) 0 (0.0)
Lack of coordination 0 (0.0) 1 (2.4) 0 (0.0) 0 (0.0)
Respiratory difficulties 3 (7.1) 2 (4.8) 2 (4.8) 0 (0.0)
Confusion 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
* = For difference between the organophosphate spray session and the placebo spray session
a = Two sample t-test
b = Mann Whitney U-test
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There are several strengths of this study. Firstly, the
randomized, double-blind, placebo-controlled study
design makes it possible to evaluate self-reported symp-
toms as a proxy for acute organophosphate poisoning.
Secondly, by measuring follow up just after the spray
session, this study has strictly assessed acute organo-
phosphate poisoning. Thirdly, work practices and cloth-
ing were directly observed during spray sessions thus
limiting recall and report bias to the self-reported
symptoms.
Major limitations are first of all the non-exposure
washout period of 7 days which may have been inad-
equate in order for PchE to reach its true unexposed
baseline activity as a study suggests this may take around
50 days [14]. However, there was no difference in the
baseline levels between the organophosphate and pla-
cebo spray session for each group, indicating that the
washout period was successful. To evaluate whether our
farmers to some extent have been exposed with a
chronic depression in PchE activity at the baseline mea-
surements it would have been of interest to compare our
baseline PchE measurements with measurements on
non-exposed individuals. However, due to the wide
inter-individual variation in PchE activity, we would have
needed a substantial number of non-exposed individuals
to establish a normal value but this was not possible
within our research frame. At the same time, a reference
value for PchE activity in a population comparable to
our population could not be found in the literature [6,
14]. Ideally, we should have measured the farmers’ PchE
levels in off-season and compared with levels within sea-
son to see if a seasonal PchE depression had taking place
as previous studies from Nepal and Pakistan have found
a depression in AchE and PchE activity when comparing
farmers’ levels in spray-season with their levels in off-
season [19, 20]. This was not possible within our study
but it implies that we, more strictly speaking, may have
evaluated “acute-on-chronic” pesticide exposure and
poisoning. Other limitations include not involving the
farmers in the pesticide mixing and loading which might
have resulted in the exposure of a lower pesticide
concentration than during their usual work. Lastly, the
sampling technique on what may seem like a small sam-
ple size might hinder generalizations to farmers in other
parts of Nepal. However, the farmers seemed representa-
tive in terms of pesticides usually used, work practices
and clothing compared to findings from previous studies
in Nepal [9, 20, 21], and we expect that our results will
be relevant to other farmers spraying with moderately
hazardous pesticides.
Conclusions
In conclusion, self-reported symptoms seem to be a poor
proxy for acute organophosphate poisoning, as there
was a general presence of acute organophosphate poi-
soning symptoms among the farmers regardless of or-
ganophosphate exposure or poisoning indicating that
the occurrence of these symptoms is not necessarily as-
sociated with acute organophosphate poisoning. Future
studies are needed to determine the reproducibility and
generalizability of our data.
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